Wedbush Securities Inc

SEC CIK: 0001142495
Latest filing: Jul 28, 2026

SEC filings (opens in a new tab)

MLTX holding history

MoonLake Immunotherapeutics in every 13F filed by Wedbush Securities Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MLTX overview All 13F holders of MLTX Full Q2 2026 holdings

Shares (Q1 2024): 0; Sold out in Q1 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2023

Holdings of MLTX by Wedbush Securities Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2024	0	$0	0.0%	−4,455−100.0%	Sold out	Holders
Q4 2023	4,455	$269.0K	<0.1%	+329+8.0%	Added	Holders
Q3 2023	4,126	$235.0K	<0.1%	−2,764−40.1%	Reduced	Holders
Q2 2023	6,890	$351.0K	<0.1%	+6,890	New	Holders